The B cell Ag receptor (BCR) has two important functions: first, it binds and takes up Ag for presentation to T lymphocytes; and second, it transmits signals that regulate B cell development. Normal expression of the BCR requires the association of the Ag binding subunit, membrane IgM (mIgM), with the signaling component, the Ig-αβ heterodimer. After assembly in the endoplasmic reticulum, the intact BCR travels through the secretory pathway to the cell surface. In this paper, we report two variants of the B lymphoma cell lines, WEHI 279 and WEHI 231, that have both lost the ability to express μ heavy chain and consequently do not express mIgM. However, these variants do express the Ig-αβ heterodimer. In one variant, WEHI 279*, the Ig-αβ remained trapped intracellularly in the absence of mIgM. The other variant, 303.1.5.LM, expressed an aberrantly glycosylated Ig-αβ on the cell surface that was capable of signaling after cross-linking with anti-Ig-β Abs. Further characterization uncovered a point mutation in the 303.1.5.LM mb1 gene that would change a proline for a leucine in the extracellular domain of Ig-α. The 303.1.5.LM Ig-αβ could not associate with a wild-type mIgM after μ heavy chain was reconstituted by DNA transfection. Thus, this mutation could define a region of the Ig-α polypeptide that is important for recognition by the endoplasmic reticulum quality control system, for association with glycosylating enzymes, and for the association of Ig-αβ subunits with mIgM subunits to create a complete BCR complex.